文献速递间质性肺疾病

澳大利亚特发性肺纤维化最佳诊疗的障碍与促进因素

Barriers and facilitators to best care for idiopathic pulmonary fibrosis in Australia.
PubMed 文献 · Respirology · 2021-11-15

该研究通过问卷调查和半结构化访谈,调查了澳大利亚公立医院特发性肺纤维化(IPF)诊疗的组织方式与最佳实践指南的一致性,并识别障碍与促进因素。结果显示多数医院有MDM且诊疗总体符合指南,但心理支持、临床试验可及性有限,区域地区存在人员与资源障碍;远程医疗被视为促进因素。

要点

  • 澳大利亚多数医院IPF诊疗符合最佳实践指南,但心理支持和临床试验可及性有限。
  • 区域地区存在人员不足、缺乏护士协调员和资金模式等障碍,导致专科服务可及性不均。
  • 远程医疗技术被认为是促进最佳诊疗的因素。

核心结论

  • 澳大利亚IPF临床管理总体符合最佳实践指南,但专科服务可及性存在一定不公平,尤其在区域地区,需加以解决以确保所有人获得最佳诊疗。

研究设计与样本

  • 2020年2月至7月通过研究专用问卷收集澳大利亚公立医院IPF诊疗组织数据。

主要发现

  • 近所有医院(n=38,97%)为诊断IPF举行多学科会议(MDM),90%的多学科团队包括呼吸科专家和放射科医生,但风湿科医生、间质性肺疾病护士和组织病理学家常不可用。
  • 超过90%机构可获得氧疗、肺康复和预先护理计划,但心理支持和临床试验的可及性有限(分别为53%和58%)。
  • 区域受访者报告了人员不足、缺乏护士协调员、临床试验可及性不足和资金模式相关的障碍。
  • 远程医疗技术被视为最佳诊疗的促进因素。

临床怎么用

  • 临床管理中应关注心理支持和临床试验的可及性,并针对区域地区人员与资源障碍采取改进措施。
  • 可利用远程医疗技术促进IPF最佳诊疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: In Australia, little is known about delivery of care for people with idiopathic pulmonary fibrosis (IPF). This study examined the organization of IPF care across Australia, how it aligns with guidance for best practice, and identified barriers and facilitators to best care. METHODS: Data on the organization of IPF care in Australia were collected from public hospitals using a study-specific questionnaire between February and July 2020. Semi-structured telephone interviews were conducted with respiratory physicians from around Australia between April and December 2020. Interviews were transcribed verbatim and thematic analysis was undertaken. RESULTS: Almost all hospitals (n = 38, 97%) held multidisciplinary meetings (MDMs) for diagnosing IPF, with 90% of multidisciplinary teams including expert respiratory physicians and radiologists; however, rheumatologists, interstitial lung disease nurses and a histopathologist were often not available. More than 90% of institutions had access to oxygen therapy, pulmonary rehabilitation and advanced care planning, but access to psychological support and clinical trials was limited (53% and 58%, respectively). Fifteen respiratory physicians (27% regional) were interviewed. Approaches to diagnosis, treatment and access to referral services were generally consistent with best practice guidance; however, regional respondents reported barriers related to inadequate staffing, lack of a nurse coordinator, inadequate access to clinical trials and funding models. Telehealth technologies were perceived as facilitators to best care. CONCLUSION: Clinical management of IPF in Australia generally aligns with best practice guidance, but there may be some inequity of access to specialist services, particularly in regional areas, that should be addressed to ensure optimal care for all.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Tikellis G, Corte TJ, Teoh AKY, et al. Barriers and facilitators to best care for idiopathic pulmonary fibrosis in Australia. Respirology. 2021. PMID: 34783108. doi:10.1111/resp.14185

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。